JLJiawei Li

Jiawei Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jiawei Li has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    NF Erythroid 2-Related Factor 2 Deficiency Enhances the Immunosuppressive Function of Monocytic Myeloid-Derived Suppressor Cells in a Peroxisome Proliferator-Activated Receptor-γ-Dependent Manner

    by Yichen Jia, Jiawei Li, Tianying Yang, Ruimin Li, Guowei Tu, Yue Qiu, Xuepeng Zhang, Ruirui Sang, Yi Shi, Shihao Xu, et al.

    Key Points: NF erythroid 2–related factor 2 (Nrf2) deficiency enhances the immunosuppressive function of monocytic myeloid-derived suppressor cells and ultimately ameliorates acute and chronic inflammatory disease in mice. The suppressive role of Nrf2−/− monocytic myeloid-derived suppressor cells could be attributed to increased levels of inducible nitric oxide synthase but decreased Arg1, the peroxisome proliferator-activated receptor- γ -dependent activation mechanism. Background: Myeloid-derived suppressor cells (MDSCs) comprise monocytic MDSCs (M-MDSCs) and granulocytic MDSCs (G-MDSCs), both of which are effective for controlling T-cell responses. Although NF erythroid 2–related factor 2 (Nrf2) participates in the expansion of MDSCs and MDSC-mediated immunosuppression, the underlying mechanisms of Nrf2 in MDSC differentiation remain poorly understood. Methods: In this study, G-MDSCs or M-MDSCs were induced and sorted from the bone marrow of wild-type (WT) or Nrf2 −/− mice using flow cytometry in vitro , with or without GW9662 treatment. Mouse models of tumorigenesis, AKI, and CKD were used to evaluate the immunosuppressive function of WT or Nrf2 −/− M-MDSCs treated with or without GW9662. Histologic analysis was performed to evaluate tumor angiogenesis or kidney injury. Immunohistochemical staining was used to evaluate lymphocyte infiltration in kidney. Masson trichrome and Sirius red staining were performed to evaluate kidney fibrosis. In addition, RNA sequencing was conducted to identify gene expression difference between WT and Nrf2 −/− M-MDSCs, with real-time PCR or western blot used to validate key findings. Results: The immunosuppressive function of M-MDSCs generated from bone marrow of Nrf2 −/− mice and sorted from Nrf2 −/− tumor-bearing mice was dramatically enhanced compared with the G-MDSC counterparts. Moreover, M-MDSCs with an Nrf2 deficiency could effectively ameliorate the inflammatory disorders in mice with AKI or CKD. Intriguingly, the efficacy of Nrf2 −/− M-MDSCs could be attributed to increased expression of inducible nitric oxide synthase but decreased levels of arginase 1, indicating an unconventional mechanism of activation. Further mechanistic studies using RNA sequencing and bioinformatics analyses identified an essential role of peroxisome proliferator-activated receptor- γ in the differentiation and suppressive ability of Nrf2 −/− M-MDSCs with which the effect could be markedly blocked with GW9662, a specific peroxisome proliferator-activated receptor- γ inhibitor. Conclusions: Our findings elucidate an immunoregulatory mechanism of Nrf2 deficiency related to M-MDSC function and provides a foundation for the application of Nrf2 −/− M-MDSCs in inflammatory diseases.


  • Phillyrin and its metabolites exert antipyretic effects by targeting the NAD+ binding domain of GAPDH, MDH2 and IDH2

    by Wenjuan Liu, Junjie Li, Sihan Xu, Yixu Wang, Jiawei Li, Shou Wang, Li Fu, Min Jiang, Gang Bai


  • Open Access

    MDSi: Multi-omics Database for Setaria italica

    by Xukai Li, Siyu Hou, Mengmeng Feng, Rui Xia, Jiawei Li, Sha Tang, Yuanhuai Han, Jianhua Gao, Xingchun Wang

    Background: Foxtail millet (Setaria italica) harbors the small diploid genome (~ 450 Mb) and shows the high inbreeding rate and close relationship to several major foods, feed, fuel and bioenergy grasses. Previously, we created a mini foxtail millet, xiaomi, with an Arabidopsis-like life cycle. The de novo assembled genome data with high-quality and an efficient Agrobacterium-mediated genetic transformation system made xiaomi an ideal C4 model system. The mini foxtail millet has been widely shared in the research community and as a result there is a growing need for a user-friendly portal and intuitive interface to perform exploratory analysis of the data. Results: Here, we built a Multi-omics Database for Setaria italica (MDSi, http://sky.sxau.edu.cn/MDSi.htm), that contains xiaomi genome of 161,844 annotations, 34,436 protein-coding genes and their expression information in 29 different tissues of xiaomi (6) and JG21 (23) samples that can be showed as an Electronic Fluorescent Pictograph (xEFP) in-situ. Moreover, the whole-genome resequencing (WGS) data of 398 germplasms, including 360 foxtail millets and 38 green foxtails and the corresponding metabolic data were available in MDSi. The SNPs and Indels of these germplasms were called in advance and can be searched and compared in an interactive manner. Common tools including BLAST, GBrowse, JBrowse, map viewer, and data downloads were implemented in MDSi. Conclusion: The MDSi constructed in this study integrated and visualized data from three levels of genomics, transcriptomics and metabolomics, and also provides information on the variation of hundreds of germplasm resources that can satisfies the mainstream requirements and supports the corresponding research community.


  • Open Access

    Consensus Division in an Arbitrary Ratio

    by Paul W. Goldberg, Jiawei Li

    We consider the problem of partitioning a line segment into two subsets, so that $n$ finite measures all have the same ratio of values for the subsets. Letting $\alpha\in[0,1]$ denote the desired ratio, this generalises the PPA-complete consensus-halving problem, in which $\alpha=\frac{1}{2}$. Stromquist and Woodall showed that for any $\alpha$, there exists a solution using $2n$ cuts of the segment. They also showed that if $\alpha$ is irrational, that upper bound is almost optimal. In this work, we elaborate the bounds for rational values $\alpha$. For $\alpha = \frac{\ell}{k}$, we show a lower bound of $\frac{k-1}{k} \cdot 2n - O(1)$ cuts; we also obtain almost matching upper bounds for a large subset of rational $\alpha$. On the computational side, we explore its dependence on the number of cuts available. More specifically, 1. when using the minimal number of cuts for each instance is required, the problem is NP-hard for any $\alpha$; 2. for a large subset of rational $\alpha = \frac{\ell}{k}$, when $\frac{k-1}{k} \cdot 2n$ cuts are available, the problem is in PPA-$k$ under Turing reduction; 3. when $2n$ cuts are allowed, the problem belongs to PPA for any $\alpha$; more generally, the problem belong to PPA-$p$ for any prime $p$ if $2(p-1)\cdot \frac{\lceil p/2 \rceil}{\lfloor p/2 \rfloor} \cdot n$ cuts are available.

  • Open Access

    Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis

    by Yanru Wang, Xiaojie Jin, Qin Fan, Chenghao Li, Min Zhang, Yongfeng Wang, Qingfeng Wu, Jiawei Li, Xiuzhu Liu, Siyu Wang, et al.

    The Huashi Baidu Formula (HSBDF), a key Chinese medical drug, has a remarkable clinical efficacy in treating acute lung injury (ALI), and it has been officially approved by the National Medical Products Administration of China for drug clinical trials. Nevertheless, the regulated mechanisms of HSBDF and its active compounds in plasma against ALI were rarely studied. Based on these considerations, the key anti-inflammatory compounds of HSBDF were screened by molecular docking and binding free energy. The key compounds were further identified in plasma by LC/MS. Network pharmacology was employed to identify the potential regulatory mechanism of the key compounds in plasma. Next, the network pharmacological prediction was validated by a series of experimental assays, including CCK-8, EdU staining, test of TNF-α, IL-6, MDA, and T-SOD, and flow cytometry, to identify active compounds. Molecular dynamic simulation and binding interaction patterns were used to evaluate the stability and affinity between active compounds and target. Finally, the active compounds were subjected to predict pharmacokinetic properties. Molecular docking revealed that HSBDF had potential effects of inhibiting inflammation by acting on IL-6R and TNF-α. Piceatannol, emodin, aloe-emodin, rhein, physcion, luteolin, and quercetin were key compounds that may ameliorate ALI, and among which, there were five compounds (emodin, aloe-emodin, rhein, luteolin, and quercetin) in plasma. Network pharmacology results suggested that five key compounds in plasma likely inhibited ALI by regulating inflammation and oxidative damage. Test performed in vitro suggested that HSBDF (0.03125 mg/ml), quercetin (1.5625 μM), emodin (3.125 μM), and rhein (1.5625 μM) have anti-inflammatory function against oxidative damage and decrease apoptosis in an inflammatory environment by LPS-stimulation. In addition, active compounds (quercetin, emodin, and rhein) had good development prospects, fine affinity, and stable conformations with the target protein. In summary, this study suggested that HSBDF and its key active components in plasma (quercetin, emodin, and rhein) can decrease levels of pro-inflammatory factors (IL-6 and TNF-α), decrease expression of MDA, increase expression of T-SOD, and decrease cell apoptosis in an inflammatory environment. These data suggest that HSBDF has significant effect on anti-inflammation and anti-oxidative stress and also can decrease cell apoptosis in treating ALI. These findings provided an important strategy for developing new agents and facilitated clinical use of HSBDF against ALI.


  • Open Access

    Single-cell Sequencing in the Field of Stem Cells

    by Tian Chen, Jiawei Li, Yichen Jia, Jiyan Wang, Ruirui Sang, Yi Zhang, Ruiming Rong

    Variation and heterogeneity between cells are the basic characteristics of stem cells. Traditional sequencing analysis methods often cover up this difference. Single-cell sequencing technology refers to the technology of high-throughput sequencing analysis of genomes at the single-cell level. It can effectively analyze cell heterogeneity and identify a small number of cell populations. With the continuous progress of cell sorting, nucleic acid extraction and other technologies, single-cell sequencing technology has also made great progress. Encouraging new discoveries have been made in stem cell research, including pluripotent stem cells, tissue-specific stem cells and cancer stem cells. In this review, we discuss the latest progress and future prospects of single-cell sequencing technology in the field of stem cells.


  • Open Access

    Selenium nanoparticles as new strategy to potentiate γδ T cell anti-tumor cytotoxicity through upregulation of tubulin-α acetylation

    by Yi Hu, Ting Liu, Jingxia Li, Fengyi Mai, Jiawei Li, Yan Chen, Yanyun Jing, Xin Dong, Li Lin, Junyi He, et al.


  • Open Access

    Downregulation of endothelin A receptor (ETaR) ameliorates renal ischemia reperfusion injury by increasing nitric oxide production

    by Long Li, Xia Wang, Long Zheng, Jiawei Li, Ming Xu, Ruiming Rong, Tongyu Zhu, Yichen Jia


  • The Value of Acetylcholine Receptor Antibody in Children with Postural Tachycardia Syndrome

    by Jiawei Li, Qingyou Zhang, Ying Liao, Chunyu Zhang, Hongjun Hao, Junbao Du

    Postural tachycardia syndrome (POTS) is characterized by symptoms of orthostatic intolerance. Antibodies of acetylcholine receptor (AChR-ab) affect acetylcholine transmission between the ganglia and result in imbalance of the autonomic nervous system in POTS. This study was designed to analyze the clinical characteristics of POTS patients with AChR-ab positive and explore the value of AChR-ab in children with POTS. In 82 children with POTS, twenty patients (24.39 %) were found as AChR-ab positive. Their clinical characteristics and hemodynamic responses to orthostatic changes were compared with the remaining 60 patients with negative AChR-ab. Symptoms of POTS children with AChR-ab positive were significantly severe than those of AChR-ab negative patients (p = 0.001). Preceding infection was predominant in patients with AChR-ab positive compared with that of patients with AChR-ab negative (p < 0.001). Syncope and fatigue were more common in the AChR-ab positive patients (p < 0.05). The change of upright heart rate was increased significantly in AChR-ab positive patients compared with AChR-ab negative cases (p = 0.013). Multiple logistic regression analysis revealed that preceding infection (OR 22.356, 95 % CI 2.151–34.920), syncope (OR 11.570, 95 % CI 2.098–63.810), and fatigue (OR 11.145, 95 % CI 1.658–74.911) were independent risk factors for POTS with AChR-ab positive. In conclusion, POTS with positive AChR-ab was a heterogeneous disorder. Preceding infection, syncope and fatigue were their main clinical characteristics.